Can exosomes predict sudden heart death? new study seeks answers

NCT ID NCT06856993

Recruiting now Knowledge-focused Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at tiny particles called exosomes in the blood of 300 people who experienced sudden cardiac death after a heart attack. Researchers want to see if certain molecules in these particles can help predict who is at highest risk. The goal is to improve early warning and care for heart attack patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better early detection tools for patients at risk of sudden cardiac death after a heart attack.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change patient care, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome Death, Sudden, Cardiac sudden arrhythmia death syndrome sudden cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CLINICAL PROGNOSIS EXOSOME MULTIOMICS SUDDEN CARDIAC DEATH

Contacts and locations

Show contact details

Locations

Nanjing Drum Tower Hospital
RECRUITING

Nanjing, Jiangsu, 210008, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.